COVID-19: Race to Therapeutic Development
Friday, June 12, 2020, 11:30 AM - 1:00 PM EDT
The New York Academy of Sciences
This webinar will provide information on the latest developments in treatments for COVID-19 and address key questions, including: what existing antiviral drugs—like Remdesivir—might be effectively repurposed to treat COVID-19? Can antibodies taken from recovered COVID-19 patients be infused into someone recently infected with the virus and successfully stave off disease? What’s the vision for new therapeutic development and pandemic response in the long term?
University of Pennsylvania
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation